US Patent 12134767 Materials and methods for treatment of hemoglobinopathies
Patent 12134767 was granted and assigned to Vertex Pharmaceuticals on November, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 23, 2020
0
Date of Patent
November 5, 2024
0
Patent Applicant
Patent Application Number
16909283
0
Patent Citations
Patent Inventor Names
Matthew Hebden Porteus
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 12134767 Materials and methods for treatment of hemoglobinopathies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
